MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Apoptosis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Apoprotein(a) < Apoptosis < Apoptosis Regulatory Proteins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000393 (2019) Florian Kleinegger [Autriche] ; Eva Hofer [Autriche] ; Christina Wodlej [Autriche] ; Nicole Golob-Schwarzl [Autriche] ; Anna Maria Birkl-Toeglhofer [Autriche] ; Alexander Stallinger [Autriche] ; Johannes Petzold [Autriche] ; Anna Orlova [Autriche] ; Stefanie Krassnig [Autriche] ; Robert Reihs [Autriche] ; Tobias Niedrist [Autriche] ; Harald Mangge [Autriche] ; Young Nyun Park [Corée du Sud] ; Michael Thalhammer [Autriche] ; Ariane Aigelsreiter [Autriche] ; Sigurd Lax [Autriche] ; Christoph Garbers [Allemagne] ; Peter Fickert [Autriche] ; Stefan Rose-John [Allemagne] ; Richard Moriggl [Autriche] ; Beate Rinner [Autriche] ; Johannes Haybaeck [Allemagne]Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
000421 (2019) Yueh-Shan Weng [Taïwan] ; Hong-Yu Tseng [Taïwan] ; Yen-An Chen [Taïwan] ; Pei-Chun Shen [Taïwan] ; Aushia Tanzih Al Haq [Taïwan] ; Li-Mei Chen [Taïwan] ; Yi-Chung Tung [Taïwan] ; Hsin-Ling Hsu [Taïwan]MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
000882 (2018) Amany El-Shahawy Abdel-Maged [Égypte] ; Amany M. Gad [Égypte] ; Amal Kamal Abdel-Aziz [Égypte] ; Mohammad M. Aboulwafa [Égypte] ; Samar S. Azab [Égypte]Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis.
000B67 (2017) Laurence S C. Lok [Royaume-Uni] ; Neda Farahi [Royaume-Uni] ; Jatinder K. Juss [Royaume-Uni] ; Chrystalla Loutsios [Royaume-Uni] ; Chandra K. Solanki [Royaume-Uni] ; Adrien M. Peters [Royaume-Uni] ; Francis Donaldson [Royaume-Uni] ; Benjamin Porter-Brown [Royaume-Uni] ; Edwin R. Chilvers [Royaume-Uni]Effects of tocilizumab on neutrophil function and kinetics.
000C23 (2017) Susan R. Mallery [États-Unis] ; Daren Wang [États-Unis] ; Brian Santiago [États-Unis] ; Ping Pei [États-Unis] ; Steven P. Schwendeman [États-Unis] ; Kari Nieto [États-Unis] ; Richard Spinney [États-Unis] ; Meng Tong [États-Unis] ; George Koutras [États-Unis] ; Brian Han [États-Unis] ; Andrew Holpuch [États-Unis] ; James Lang [États-Unis]Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.
000C96 (2016) Shaojun Wang [République populaire de Chine] ; Jun Zhou ; Weijie Kang ; Zhaoni Dong ; Hezuo WangTocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model.
000E34 (2016) Yuichiro Matsuoka [Japon] ; Hideki Nakayama [Japon] ; Ryoji Yoshida [Japon] ; Akiyuki Hirosue [Japon] ; Masashi Nagata [Japon] ; Takuya Tanaka [Japon] ; Kenta Kawahara [Japon] ; Junki Sakata [Japon] ; Hidetaka Arita [Japon] ; Hikaru Nakashima [Japon] ; Satoru Shinriki [Japon] ; Daiki Fukuma [Japon] ; Hidenao Ogi [Japon] ; Akimitsu Hiraki [Japon] ; Masanori Shinohara [Japon] ; Ryo Toya [Japon] ; Ryuji Murakami [Japon]IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.
000F29 (2016) Xinran Chen [République populaire de Chine] ; Ling Wang [République populaire de Chine] ; Wei Wang [République populaire de Chine] ; Lianmei Zhao [République populaire de Chine] ; Baoen Shan [République populaire de Chine]B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.
000F79 (2015) Christoph Minichsdorfer [Autriche] ; Christine Wasinger ; Evelyn Sieczkowski ; Bihter Atil ; Martin HoheneggerTocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells.
001008 (2015) Hiroki Goto [Japon] ; Eriko Kudo ; Ryusho Kariya ; Manabu Taura ; Harutaka Katano ; Seiji OkadaTargeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.
001083 (2015) Andrea M. Griesinger [États-Unis] ; Rebecca J. Josephson [États-Unis] ; Andrew M. Donson [États-Unis] ; Jean M. Mulcahy Levy [États-Unis] ; Vladimir Amani [États-Unis] ; Diane K. Birks [États-Unis] ; Lindsey M. Hoffman [États-Unis] ; Steffanie L. Furtek [États-Unis] ; Phillip Reigan [États-Unis] ; Michael H. Handler [États-Unis] ; Rajeev Vibhakar [États-Unis] ; Nicholas K. Foreman [États-Unis]Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma.
001087 (2015) Renpeng Zhou [République populaire de Chine] ; Xiaoshan Wu [République populaire de Chine] ; Zhisen Wang [République populaire de Chine] ; Jinfang Ge [République populaire de Chine] ; Feihu Chen [République populaire de Chine]Interleukin-6 enhances acid-induced apoptosis via upregulating acid-sensing ion channel 1a expression and function in rat articular chondrocytes.
001131 (2015) Toshihiro Tono [Japon] ; Satoko Aihara ; Takayuki Hoshiyama ; Yoshiyuki Arinuma ; Tatsuo Nagai ; Shunsei HirohataEffects of anti-IL-6 receptor antibody on human monocytes.
001372 (2014) Helen L. Wright [Royaume-Uni] ; Andrew L. Cross [Royaume-Uni] ; Steven W. Edwards [Royaume-Uni] ; Robert J. Moots [Royaume-Uni]Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo.
001420 (2014) Afaf Sahraoui [Norvège] ; Kristine Kloster-Jensen ; Thor Ueland ; Olle Korsgren ; Aksel Foss ; Hanne ScholzAnakinra and tocilizumab enhance survival and function of human islets during culture: implications for clinical islet transplantation.
001850 (2011) Balázs Szalay [Hongrie] ; Lilla Acs ; Barna Vásárhelyi ; Lászl Kovács ; Attila BalogSuccessful use of tocilizumab in a patient with rheumatoid arthritis following severe pancytopenia during etanercept therapy.
001A22 (2010) Claudia Drucker [Allemagne] ; Jessica Gewiese ; Sven Malchow ; Jürgen Scheller ; Stefan Rose-JohnImpact of interleukin-6 classic- and trans-signaling on liver damage and regeneration.
001D71 (????) Giuliana Guggino [Italie] ; Anna Rita Giardina ; Stefania Raimondo ; Giuseppina Giardina ; Guido Sireci ; Francesco Dieli ; Marco Peralta ; Riccardo Alessandro ; Giovanni Triolo ; Francesco CicciaTargeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Apoptosis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Apoptosis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Apoptosis
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021